RESEARCH
[Publication] Commensal consortia decolonize Enterobacteriaceae via ecological control
September 19, 2024
Fig.1: Elaboration of an 18-strain-consortium capable of decolonizing Klebsiella.
| Title |
Commensal consortia decolonize Enterobacteriaceae via ecological control |
|---|---|
| Authors | Munehiro Furuichi [1],[2],[14]; Takaaki Kawaguchi [1],[2],[14]; Marie-Madlen Pust [3],[4],[14]; Keiko Yasuma-Mitobe [1],[14]; Damian R. Plichta [3]; Naomi Hasegawa [1]; Takashi Ohya [1],[2]; Shakti K. Bhattarai [5]; Satoshi Sasajima [1]; Yoshimasa Aoto [6]; Timur Tuganbaev [1],[7]; Mizuki Yaginuma [1]; Masahiro Ueda [2],[6]; Nobuyuki Okahashi [2],[8],[9]; Kimiko Amafuji [6]; Yuko Kiridoshi [6]; Kayoko Sugita [1]; Martin Stražar [3]; Julian Avila-Pacheco [3]; Kerry Pierce [3]; Clary B. Clish [3]; Ashwin N. Skelly [1]; Masahira Hattori [2],[10]; Nobuhiro Nakamoto [11]; Silvia Caballero [12]; Jason M. Norman [12]; Bernat Olle [12]; Takeshi Tanoue [1],[2]; Wataru Suda [2],[10]; Makoto Arita [2],[7],[9]; Vanni Bucci [5]; Koji Atarashi [1],[2],[7]; Ramnik J. Xavier [3],[4],[13] & Kenya Honda [1],[2],[7] |
| DOI | https://doi.org/10.1038/s41586-024-07960-6 |
| Journal | Nature |
| Vol/Num/Page | 633, 878–886 (2024) |
| Published Date | 18 September 2024 |
Affiliations:
[1] Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
[2] RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
[3] Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
[4] Center for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
[5] Department of Microbiology and Physiological Systems, Program in Microbiome Dynamics, UMass Chan Medical School, Worcester, MA, USA.
[6] JSR-Keio University Medical and Chemical Innovation Center, Keio University School of Medicine, Tokyo, Japan.
[7] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, Tokyo, Japan.
[8] Department of Bioinformatic Engineering, Graduate School of Information Science and Technology, Osaka University, Osaka, Japan.
[9] Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
[10] Cooperative Major in Advanced Health Science, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
[11] Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
[12] Vedanta Biosciences, Cambridge, MA, USA.
[13] Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
[14] These authors contributed equally: Munehiro Furuichi, Takaaki Kawaguchi, Marie-Madlen Pust, Keiko Yasuma-Mitobe.
More Bio2Q News
【12/12 Event】KEIO TECHNO-MALL 2025
The World Premier International Research Center (WPI) Keio University Human Biology-Microbiome-Quantum Research Center (Bio2Q) will exhibit ...
WPI-Bio2Q now recruiting administrative staff– Deadline: January 12, 2026
WPI-Bio2Q Administrative Office is currently hiring administrative staff. We look forward to receiving applications from candidates with ...
The 4th Keio University WPI-Bio2Q International Symposium
The 4th Keio University WPI-Bio2Q International Symposium, entitled “Integration of Biology, Microbiome, and Metabolomics for Healthy Longev...
COMPREHENSIVE SUPPORT FOR STARTING LIFE IN JAPAN
As part of our support for newcomers to Japan, Bio2Q has launched a welcome airport arrival assistance service under the Bio2Q Connect progr...
Inaugural Bio2Q "LEAD50" Lectureship Held
The 30th Keio Medical Science Prize Ceremony and Commemorative Lecture was held at the Kitasato Hall on Shinanomachi Campus on Tuesday, Nove...

